Minipig Toxicology Study I Pharmaron CRO Services

This study investigates the pharmacokinetics, efficacy, and safety of intramuscular (IM) and intranasal (IN) administration of the sedative dexmedetomidine in Yucatan minipigs, offering critical insights into its potential for research applications. Dexmedetomidine, an alpha-2 adrenergic agonist known for reduced adverse effects compared to xylazine, was evaluated to determine its reliability as a sedative.

Yucatan minipigs were administered IM and IN doses of dexmedetomidine, alongside a control group receiving xylazine. Comprehensive safety evaluations included:

sedation scoring
pharmacokinetic blood sampling
heart and respiratory rate measurements
hematology and clinical chemistry assessments

The findings demonstrated effective sedation with dexmedetomidine, reduced bradycardic effects compared to xylazine, and stable liver and renal function for both routes.

This research underlines dexmedetomidine’s promise as a safe sedative for minipig studies.

Download the full poster to view the minipig toxicology study and research services.

Name(Required)

First Last

Company Name(Required)

Job Title(Required)

Country(Required)

State(Required)

Message

Email(Required)

This field is hidden when viewing the form

Lead Source(Required)

By completing and submitting this form, you acknowledge that you have read and understood our Privacy Policy, and you consent to the collection and processing of your personal data by Pharmaron for the purpose of responding to your inquiry. You also agree to be contacted by Pharmaron regarding relevant services and updates. You may withdraw your consent at any time.